Yuki Kageyama to Neoplasms
This is a "connection" page, showing publications Yuki Kageyama has written about Neoplasms.
Connection Strength
0.070
-
Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review. Clin Genitourin Cancer. 2021 06; 19(3):208-216.e1.
Score: 0.063
-
Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases. J Urol. 2008 Aug; 180(2):618-21; discussion 621.
Score: 0.007